316 results found for 'google日本語版咨询QQ：4826193 伊宁市搜索引擎磁力柠檬,yahoo mail app for windows'.
New Unitaid report: World’s leading HIV drug proven to have reduced global CO2 emissions by 26 million tons
News | 15 July 2024
...to a treatment formulation that requires less active ingredient. The adoption of DTG reduced the health sector’s overall carbon footprint in low- and middle-income countries by approximately 0.3-0.4%, a magnitude...
Partnership critical to reducing maternal mortality, says Sierra Leonean Minister of Health, welcoming Unitaid report
News | 23 September 2024
...optimal management of severe cases; and increasing antenatal attendance (now at 87%) and quality so that women with pre-eclampsia are identified early and the appropriate care is provided. But all...
In advance of International Women’s Day, Unitaid Board Chair calls for urgent action to advance access to cervical cancer prevention for women in resource-limited settings
News | 06 March 2024
...precancerous cervical cells. Between 2019 and 2023, our programs reached approximately 1.5 million women on three continents, trained tens of thousands of health workers and greatly expanded the number of...
Three new agreements announced with the potential to expand access to innovative HIV treatment in low- and middle-income countries
News | 30 November 2015
...begin providing DTG to suitable patients as soon as regulatory approval is received. ViiV Healthcare licensed Aurobindo for generic DTG, enabling Aurobindo to file for tentative approval with the U.S....
Call for PRC membership applications March 2022
News | 11 March 2022
...past the indicated deadline will not be considered. N.B. An application is considered submitted only once you receive an e-mail message of confirmation of receipt from Unitaid. The letter of...
Unitaid renews call for clear access strategy after positive results from Gilead’s PURPOSE 2 lenacapavir trial
News | 13 September 2024
...trials and for ensuring geographical diversity in the studies. This strategic approach can expedite access and impact for those most at risk. However, without affordable and sufficient supply, the full...
WHO recommendations, supported by Unitaid clinical trials, now allow for better treatment for all people with drug-resistant TB, including children and pregnant women
News | 23 August 2024
...better outcomes and significantly shortened the treatment duration to six months, BPaLM has not been approved for the treatment of key populations such as children, adolescents, pregnant and breastfeeding women,...
Unitaid ready to invest immediately to support accelerated global access to lenacapavir
News | 02 October 2024
...and implementation support to the generic manufacturers, thereby mitigating development and regulatory risks, accelerating approval timelines, and ensuring a strategy that enables a successful launch. Alongside key stakeholders, we are...
Enabling a market-based approach to manufacturing quality-assured health products in Africa: A differentiated coordination approach
Publication